Published 09/18/2024 8:32:51 a.m.

Noom offers cut-price compounded GLP-1 drug for obesity

Summary by Pharmaphorum

Digital health company Noom has said it intends to launch a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide

0 Articles

All

Left

Center

Right

Digital health company Noom has said it intends to launch a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated09/18/2024 6:52:58 p.m.Bias Distribution

No sources with tracked biases.

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)